Yoshioka K, Miki T, Katsuya T, Ogihara T, Sakaki Y
Research Laboratory for Genetic Information, Kyushu University, Fukuoka, Japan.
Biochem Biophys Res Commun. 1991 Aug 15;178(3):1141-6. doi: 10.1016/0006-291x(91)91011-z.
Alzheimer's disease (AD) is a devastating neurological disorder and the leading cause of dementia among aged individuals. The human amyloid beta protein, which is a cleavage product of amyloid precursor protein (APP), is a major component of the amyloid deposited in the brain of patients with AD. By using PCR direct sequencing of exon 17 (encoding part of the beta protein) of the APP gene, we have found that a Japanese AD patient harbours a C to T substitution, responsible for a valine to isoleucine change at position 717, heterogeneously. The mutation is exactly the same as that found in a Caucasian AD family by Goate et al. (1). Furthermore, the mutation was shown to co-segregate with AD in his family. These results suggest that the Val----Ile change in the APP causes AD, regardless of ethnic background.
阿尔茨海默病(AD)是一种具有毁灭性的神经疾病,也是老年人痴呆的主要病因。人淀粉样β蛋白是淀粉样前体蛋白(APP)的裂解产物,是AD患者大脑中沉积的淀粉样蛋白的主要成分。通过对APP基因第17外显子(编码β蛋白的一部分)进行PCR直接测序,我们发现一名日本AD患者存在C到T的替换,该替换导致第717位缬氨酸变为异亮氨酸,且呈异质性。该突变与Goate等人(1)在一个高加索AD家族中发现的突变完全相同。此外,该突变在其家族中与AD共分离。这些结果表明,APP中缬氨酸到异亮氨酸的变化会导致AD,而与种族背景无关。